• FDA approves biosimilar for infliximab

    One year ago - By Healio

    Today, the FDA has approved Merck and Samsung Bioepis' infliximab biosimilar for injection, which is known as infliximab-abda . It will maintain the same indications as the reference product.Infliximab is indicated for Crohn's disease, pediatric Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
    Read more ...


  • FDA Clears Second Remicade Biosimilar

    One year ago - By Medscape

    The FDA approves infliximab-abda for multiple indications.
    FDA Approvals
    Read more ...